These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15464384)

  • 21. Imaging of cell proliferation: status and prospects.
    Bading JR; Shields AF
    J Nucl Med; 2008 Jun; 49 Suppl 2():64S-80S. PubMed ID: 18523066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
    Lee SJ; Yeo JS; Lee HJ; Lee EJ; Kim SY; Jang SJ; Lee JJ; Ryu JS; Moon DH
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1327-35. PubMed ID: 24562648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine.
    Buck AK; Herrmann K; Shen C; Dechow T; Schwaiger M; Wester HJ
    Methods; 2009 Jun; 48(2):205-15. PubMed ID: 19318128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging of thymidine kinase 1 activity after 5-fluorouracil treatment in a mouse tumor model.
    Hong IK; Kim SY; Chung JH; Lee SJ; Oh SJ; Lee SJ; Oh J; Ryu JS; Kim TW; Kim DY; Moon DH
    Anticancer Res; 2014 Feb; 34(2):759-66. PubMed ID: 24511010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.
    Waldherr C; Mellinghoff IK; Tran C; Halpern BS; Rozengurt N; Safaei A; Weber WA; Stout D; Satyamurthy N; Barrio J; Phelps ME; Silverman DH; Sawyers CL; Czernin J
    J Nucl Med; 2005 Jan; 46(1):114-20. PubMed ID: 15632041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.
    Nishii R; Volgin AY; Mawlawi O; Mukhopadhyay U; Pal A; Bornmann W; Gelovani JG; Alauddin MM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):990-8. PubMed ID: 18057932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation.
    Barwick T; Bencherif B; Mountz JM; Avril N
    Nucl Med Commun; 2009 Dec; 30(12):908-17. PubMed ID: 19794320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy.
    Sengupta D; Pratx G
    J Nucl Med; 2016 Jul; 57(7):1136-40. PubMed ID: 27081170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using
    Heinzmann K; Nguyen QD; Honess D; Smith DM; Stribbling S; Brickute D; Barnes C; Griffiths J; Aboagye E
    J Nucl Med; 2018 Oct; 59(10):1558-1565. PubMed ID: 29794225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels.
    Barthel H; Perumal M; Latigo J; He Q; Brady F; Luthra SK; Price PM; Aboagye EO
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):257-63. PubMed ID: 15791434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of a localized bacterial infection with endogenous thymidine kinase using radioisotope-labeled nucleosides.
    Jang SJ; Lee YJ; Lim S; Kim KI; Lee KC; An GI; Lee TS; Cheon GJ; Lim SM; Kang JH
    Int J Med Microbiol; 2012 Mar; 302(2):101-7. PubMed ID: 22264560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorine-18-Labeled Thymidine Positron Emission Tomography (FLT-PET) as an Index of Cell Proliferation after Pharmacological Ascorbate-Based Therapy.
    Cieslak JA; Sibenaller ZA; Walsh SA; Ponto LL; Du J; Sunderland JJ; Cullen JJ
    Radiat Res; 2016 Jan; 185(1):31-8. PubMed ID: 26720803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.
    Buck AK; Schirrmeister H; Hetzel M; Von Der Heide M; Halter G; Glatting G; Mattfeldt T; Liewald F; Reske SN; Neumaier B
    Cancer Res; 2002 Jun; 62(12):3331-4. PubMed ID: 12067968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3'-Deoxy-3'-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors: comparison with 2-deoxy-2-18f-fluoro-D-glucose.
    Yamamoto Y; Nishiyama Y; Ishikawa S; Gotoh M; Bandoh S; Kanaji N; Asakura M; Ohkawa M
    J Comput Assist Tomogr; 2008; 32(3):432-7. PubMed ID: 18520552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
    Rasey JS; Grierson JR; Wiens LW; Kolb PD; Schwartz JL
    J Nucl Med; 2002 Sep; 43(9):1210-7. PubMed ID: 12215561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.
    Leyton J; Alao JP; Da Costa M; Stavropoulou AV; Latigo JR; Perumal M; Pillai R; He Q; Atadja P; Lam EW; Workman P; Vigushin DM; Aboagye EO
    Cancer Res; 2006 Aug; 66(15):7621-9. PubMed ID: 16885362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity.
    Grierson JR; Brockenbrough JS; Rasey JS; Wiens LW; Schwartz JL; Jordan R; Vesselle H
    Nucl Med Biol; 2007 Jul; 34(5):471-8. PubMed ID: 17591546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FLT PET imaging of cellular proliferation in pancreatic cancer.
    Lamarca A; Asselin MC; Manoharan P; McNamara MG; Trigonis I; Hubner R; Saleem A; Valle JW
    Crit Rev Oncol Hematol; 2016 Mar; 99():158-69. PubMed ID: 26778585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.